Benjamin Morin

Benjamin Morin is a highly motivated biochemist with over 15 years of experience in antibody/protein engineering, structural biology, and enzymology, specializing in drug development focused on immune modulators and tumor microenvironment conditioning therapeutics.

He has excelled as a team leader in antibody/protein engineering and Immuno-Oncology (IO) Research and has a strong track record in developing innovative methods for drug discovery, biologics, and small molecules.

With a proven ability to multitask effectively, Benjamin has demonstrated exceptional project management skills in scientific collaborations with academic and industry partners, along with contract research organizations.

His excellent communication and presentation abilities have been showcased through oral presentations at international conferences, and he is adept at working independently as well as within collaborative team settings.

Benjamin Morin brings a wealth of experience in successful IND and patent filings, along with a consistent publication record in reputable scientific journals.

He holds a Doctor of Philosophy (PhD) in Structural Biochemistry from Université de la Méditerranée (Aix-Marseille II) and a Master's degree in Bioinformatics, structural biochemistry, and genomics from Aix-Marseille University.

Currently, Benjamin serves as the Associate Director and Head of Biochemistry at Agenus, leveraging his expertise to drive biochemistry initiatives. Previously, he held roles as a Scientist II and Scientist at Agenus, as well as Postdoctoral Fellow at Harvard Medical School and Ph.D. in Structural Biology at CNRS.